Copyright
©The Author(s) 2020.
World J Clin Oncol. Oct 24, 2020; 11(10): 809-835
Published online Oct 24, 2020. doi: 10.5306/wjco.v11.i10.809
Published online Oct 24, 2020. doi: 10.5306/wjco.v11.i10.809
Table 2 Incidence and mortality of acute respiratory failure in cancer patients[25]
Incidence | Need for ICU admission | Hospital mortality | |
Hematological malignancy | |||
Acute myeloid leukemia | 22%-84 % | 66% | 45% |
Acute lymphoblastic leukemia | 7%-18.5% | 12%-15% | 38.5% |
Lymphoproliferative diseases | 8% | 8% | 40%-50% |
Myelodysplastic syndrome | 29.4% | 20% | 17% |
Autologous hematopoietic stem cell transplant | 3%-28% | 42% | 3%-55% |
Allogeneic hematopoietic stem cell transplant | 24%-30% | 50% | 51% |
Prolonged neutropenia | 8%-29.5% | 11%-16% | 5%-12% |
Solid tumor | |||
Lung cancer | 26%-50% | 100% | 11.2%-60% |
Other solid tumors | 0.7%-10.3% | 100% | 6.1%-55% |
Patients on immunotherapy | 1.3%-3.6% | 1.3% | - |
- Citation: Martos-Benítez FD, Soler-Morejón CD, Lara-Ponce KX, Orama-Requejo V, Burgos-Aragüez D, Larrondo-Muguercia H, Lespoir RW. Critically ill patients with cancer: A clinical perspective. World J Clin Oncol 2020; 11(10): 809-835
- URL: https://www.wjgnet.com/2218-4333/full/v11/i10/809.htm
- DOI: https://dx.doi.org/10.5306/wjco.v11.i10.809